Drug reference
loncastuximab
Antibody-drug conjugate
Antibody-drug conjugate
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Targets CD19 with pyrrolobenzodiazepine dimer cargo, leading to DNA cleavage.
Other Antibody-drug conjugate drugs
Ask House about loncastuximab
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team